Schuetz Thomas J. 4
4 · Compass Therapeutics, Inc. · Filed Feb 10, 2026
Research Summary
AI-generated summary of this filing
Compass Therapeutics (CMPX) CEO Thomas Schuetz Sells 36,687 Shares
What Happened
Thomas J. Schuetz, CEO of Compass Therapeutics (CMPX), had 36,687 shares withheld by the company on February 8, 2026 to cover tax withholding obligations related to vested restricted stock units (RSUs). The shares were valued at $6.52 each, for a total disposition of approximately $239,199. This was a tax-withholding disposition (transaction code F), not an open‑market sell.
Key Details
- Transaction date and price: 2026-02-08, 36,687 shares at $6.52 per share (total ≈ $239,199).
- Transaction type: F — shares withheld to cover tax withholding on RSU vesting (not a voluntary market sale).
- Shares owned after transaction: Not specified in the provided filing excerpt.
- Filing: Report filed 2026-02-10 for a 2026-02-08 transaction — appears timely (Form 4s are generally due within two business days).
- Footnotes:
- F1: Confirms shares were withheld by the issuer to satisfy tax withholding obligations.
- F2: Details unvested RSU awards: 125,000 RSUs granted 2/8/2023 (4-year annual vesting, first vested 2/8/2024); 318,750 RSUs granted 1/9/2024 (4-year annual vesting, first vested 1/9/2025); 250,000 RSUs granted 1/2/2026 (4-year annual vesting, first vest 1/2/2027).
Context
Tax-withholding dispositions are routine when RSUs vest: the company retains (or sells) a portion of the shares to cover withholding rather than the insider selling shares on the open market. This action reflects standard payroll tax treatment of equity compensation and does not necessarily indicate a change in the insider’s view of the company.
Insider Transaction Report
- Tax Payment
Common Stock
[F1][F2]2026-02-08$6.52/sh−36,687$239,199→ 6,603,336 total
Footnotes (2)
- [F1]Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").
- [F2]125,000 of the shares represent unvested restricted stock units ("RSU") granted on February 8, 2023. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on February 8, 2024. 318,750 of the shares represent unvested restricted stock units ("RSU") granted on January 9, 2024. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on January 9, 2025. 250,000 of the shares represent unvested restricted stock units ("RSU") granted on January 2, 2026. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on January 2, 2027.